HK Stock MarketDetailed Quotes

FUSEN PHARM (01652)

Watchlist

0.760
0.0000.00%

Trading Jan 16 09:00 CST

561.87MMarket Cap-2.92P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

FUSEN PHARM (01652) Income Statement

All

YOY

Hide blank lines

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

Turnover

-43.31%111.29M

-42.36%326.03M

-41.65%196.32M

15.02%565.61M

103.15%336.44M

27.51%491.76M

-22.69%165.61M

-20.78%385.66M

-13.45%214.21M

19.51%486.85M

Operating income

-43.31%111.29M

-42.36%326.03M

-41.65%196.32M

15.02%565.61M

103.15%336.44M

27.51%491.76M

-22.69%165.61M

-20.78%385.66M

-13.45%214.21M

19.51%486.85M

Cost of sales

24.49%-68.3M

38.60%-163.39M

42.51%-90.45M

0.24%-266.1M

-83.19%-157.32M

-52.83%-266.74M

10.53%-85.88M

20.95%-174.53M

16.30%-95.98M

-13.28%-220.79M

Operating expenses

24.49%-68.3M

38.60%-163.39M

42.51%-90.45M

0.24%-266.1M

-83.19%-157.32M

-52.83%-266.74M

10.53%-85.88M

20.95%-174.53M

16.30%-95.98M

-13.28%-220.79M

Gross profit

-59.39%42.99M

-45.70%162.64M

-40.89%105.87M

33.10%299.51M

124.65%179.12M

6.58%225.02M

-32.56%79.73M

-20.65%211.13M

-10.99%118.23M

25.22%266.07M

Selling expenses

41.41%-30.6M

41.95%-81M

33.98%-52.22M

-17.54%-139.54M

-77.36%-79.09M

-30.54%-118.72M

12.41%-44.59M

15.33%-90.95M

9.76%-50.91M

4.79%-107.41M

Administrative expenses

59.31%-14.74M

19.51%-60.29M

-1.28%-36.21M

-36.81%-74.9M

-28.14%-35.76M

16.08%-54.75M

11.50%-27.9M

17.29%-65.24M

33.98%-31.53M

-34.30%-78.87M

Research and development expenses

73.92%-14.88M

-62.98%-106.26M

-137.47%-57.06M

-329.61%-65.2M

---24.03M

---15.18M

----

Impairment and provision

----

---22.64M

-Goodwill impairment

----

---22.64M

Special items of operating profit

-196.43%-2.97M

11,814.38%17.4M

313.44%3.08M

-98.02%146K

-2,431.58%-1.44M

362.13%7.38M

-100.52%-57K

-159.46%-2.82M

119.95%11.06M

-81.21%4.73M

Operating profit

44.73%-20.19M

-437.29%-67.51M

-194.17%-36.54M

-54.26%20.02M

440.55%38.8M

-16.07%43.76M

-84.68%7.18M

-15.75%52.14M

39.10%46.85M

-6.45%61.88M

Financing income

2,989.47%587K

-94.34%24K

-97.47%19K

-78.50%424K

-21.09%752K

-22.91%1.97M

-21.37%953K

79.01%2.56M

51.69%1.21M

-60.99%1.43M

Financing cost

-13.94%-8.4M

-103.54%-18.86M

-146.41%-7.38M

47.64%-9.27M

72.50%-2.99M

-83.29%-17.7M

-53.86%-10.88M

-5.42%-9.66M

-46.37%-7.07M

13.04%-9.16M

Share of profits of associates

-284.57%-4.11M

-163.07%-77.44M

-24.45%-1.07M

-219.84%-29.44M

72.27%-859K

32.52%-9.2M

-62.20%-3.1M

---13.64M

---1.91M

----

Share of profit from joint venture company

2,702.77%9.4M

-138.34%-26.66M

97.18%-361K

5.33%-11.19M

-775.85%-12.81M

-201.26%-11.82M

-112.47%-1.46M

-51.88%11.67M

-4.17%11.72M

434.77%24.25M

Special items of earning before tax

----

-97.13%-38.01M

----

---19.28M

----

Earning before tax

49.86%-22.73M

-546.72%-190.45M

-297.96%-45.33M

4.98%-29.45M

413.09%22.9M

-230.27%-30.99M

-114.40%-7.31M

-69.66%23.79M

21.30%50.8M

22.86%78.41M

Tax

-104.91%-411K

124.04%1.65M

229.88%8.38M

-87.03%-6.85M

-2,832.63%-6.45M

49.00%-3.66M

103.38%236K

54.39%-7.18M

17.27%-6.99M

-36.19%-15.74M

After-tax profit from continuing operations

37.38%-23.14M

-420.18%-188.8M

-324.65%-36.95M

-4.74%-36.3M

332.40%16.45M

-308.60%-34.65M

-116.15%-7.08M

-73.49%16.61M

31.05%43.81M

19.92%62.67M

Earning after tax

37.38%-23.14M

-420.18%-188.8M

-324.65%-36.95M

-4.74%-36.3M

332.40%16.45M

-308.60%-34.65M

-116.15%-7.08M

-73.49%16.61M

31.05%43.81M

19.92%62.67M

Minority profit

----

5.56%-17K

11.11%-8K

63.27%-18K

77.50%-9K

-53.13%-49K

63.64%-40K

99.57%-32K

92.69%-110K

-535.15%-7.46M

Profit attributable to shareholders

37.37%-23.14M

-420.39%-188.78M

-324.48%-36.94M

-4.83%-36.28M

333.85%16.46M

-307.90%-34.61M

-116.02%-7.04M

-76.27%16.65M

25.72%43.92M

31.25%70.13M

Basic earnings per share

40.00%-0.03

-420.00%-0.26

-350.00%-0.05

0.00%-0.05

300.00%0.02

-350.00%-0.05

-116.67%-0.01

-77.78%0.02

50.00%0.06

28.57%0.09

Diluted earnings per share

40.00%-0.03

-420.00%-0.26

-350.00%-0.05

0.00%-0.05

300.00%0.02

-350.00%-0.05

-116.67%-0.01

-77.78%0.02

50.00%0.06

28.57%0.09

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

KPMG

	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020
Turnover	-43.31%111.29M	-42.36%326.03M	-41.65%196.32M	15.02%565.61M	103.15%336.44M	27.51%491.76M	-22.69%165.61M	-20.78%385.66M	-13.45%214.21M	19.51%486.85M
Operating income	-43.31%111.29M	-42.36%326.03M	-41.65%196.32M	15.02%565.61M	103.15%336.44M	27.51%491.76M	-22.69%165.61M	-20.78%385.66M	-13.45%214.21M	19.51%486.85M
Cost of sales	24.49%-68.3M	38.60%-163.39M	42.51%-90.45M	0.24%-266.1M	-83.19%-157.32M	-52.83%-266.74M	10.53%-85.88M	20.95%-174.53M	16.30%-95.98M	-13.28%-220.79M
Operating expenses	24.49%-68.3M	38.60%-163.39M	42.51%-90.45M	0.24%-266.1M	-83.19%-157.32M	-52.83%-266.74M	10.53%-85.88M	20.95%-174.53M	16.30%-95.98M	-13.28%-220.79M
Gross profit	-59.39%42.99M	-45.70%162.64M	-40.89%105.87M	33.10%299.51M	124.65%179.12M	6.58%225.02M	-32.56%79.73M	-20.65%211.13M	-10.99%118.23M	25.22%266.07M
Selling expenses	41.41%-30.6M	41.95%-81M	33.98%-52.22M	-17.54%-139.54M	-77.36%-79.09M	-30.54%-118.72M	12.41%-44.59M	15.33%-90.95M	9.76%-50.91M	4.79%-107.41M
Administrative expenses	59.31%-14.74M	19.51%-60.29M	-1.28%-36.21M	-36.81%-74.9M	-28.14%-35.76M	16.08%-54.75M	11.50%-27.9M	17.29%-65.24M	33.98%-31.53M	-34.30%-78.87M
Research and development expenses	73.92%-14.88M	-62.98%-106.26M	-137.47%-57.06M	-329.61%-65.2M	---24.03M	---15.18M	----	----	----	----
Impairment and provision	----	----	----	----	----	----	----	----	----	---22.64M
-Goodwill impairment	----	----	----	----	----	----	----	----	----	---22.64M
Special items of operating profit	-196.43%-2.97M	11,814.38%17.4M	313.44%3.08M	-98.02%146K	-2,431.58%-1.44M	362.13%7.38M	-100.52%-57K	-159.46%-2.82M	119.95%11.06M	-81.21%4.73M
Operating profit	44.73%-20.19M	-437.29%-67.51M	-194.17%-36.54M	-54.26%20.02M	440.55%38.8M	-16.07%43.76M	-84.68%7.18M	-15.75%52.14M	39.10%46.85M	-6.45%61.88M
Financing income	2,989.47%587K	-94.34%24K	-97.47%19K	-78.50%424K	-21.09%752K	-22.91%1.97M	-21.37%953K	79.01%2.56M	51.69%1.21M	-60.99%1.43M
Financing cost	-13.94%-8.4M	-103.54%-18.86M	-146.41%-7.38M	47.64%-9.27M	72.50%-2.99M	-83.29%-17.7M	-53.86%-10.88M	-5.42%-9.66M	-46.37%-7.07M	13.04%-9.16M
Share of profits of associates	-284.57%-4.11M	-163.07%-77.44M	-24.45%-1.07M	-219.84%-29.44M	72.27%-859K	32.52%-9.2M	-62.20%-3.1M	---13.64M	---1.91M	----
Share of profit from joint venture company	2,702.77%9.4M	-138.34%-26.66M	97.18%-361K	5.33%-11.19M	-775.85%-12.81M	-201.26%-11.82M	-112.47%-1.46M	-51.88%11.67M	-4.17%11.72M	434.77%24.25M
Special items of earning before tax	----	----	----	----	----	-97.13%-38.01M	----	---19.28M	----	----
Earning before tax	49.86%-22.73M	-546.72%-190.45M	-297.96%-45.33M	4.98%-29.45M	413.09%22.9M	-230.27%-30.99M	-114.40%-7.31M	-69.66%23.79M	21.30%50.8M	22.86%78.41M
Tax	-104.91%-411K	124.04%1.65M	229.88%8.38M	-87.03%-6.85M	-2,832.63%-6.45M	49.00%-3.66M	103.38%236K	54.39%-7.18M	17.27%-6.99M	-36.19%-15.74M
After-tax profit from continuing operations	37.38%-23.14M	-420.18%-188.8M	-324.65%-36.95M	-4.74%-36.3M	332.40%16.45M	-308.60%-34.65M	-116.15%-7.08M	-73.49%16.61M	31.05%43.81M	19.92%62.67M
Earning after tax	37.38%-23.14M	-420.18%-188.8M	-324.65%-36.95M	-4.74%-36.3M	332.40%16.45M	-308.60%-34.65M	-116.15%-7.08M	-73.49%16.61M	31.05%43.81M	19.92%62.67M
Minority profit	----	5.56%-17K	11.11%-8K	63.27%-18K	77.50%-9K	-53.13%-49K	63.64%-40K	99.57%-32K	92.69%-110K	-535.15%-7.46M
Profit attributable to shareholders	37.37%-23.14M	-420.39%-188.78M	-324.48%-36.94M	-4.83%-36.28M	333.85%16.46M	-307.90%-34.61M	-116.02%-7.04M	-76.27%16.65M	25.72%43.92M	31.25%70.13M
Basic earnings per share	40.00%-0.03	-420.00%-0.26	-350.00%-0.05	0.00%-0.05	300.00%0.02	-350.00%-0.05	-116.67%-0.01	-77.78%0.02	50.00%0.06	28.57%0.09
Diluted earnings per share	40.00%-0.03	-420.00%-0.26	-350.00%-0.05	0.00%-0.05	300.00%0.02	-350.00%-0.05	-116.67%-0.01	-77.78%0.02	50.00%0.06	28.57%0.09
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	--	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	KPMG	--	KPMG	--	KPMG	--	KPMG	--	KPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

No. Symbol 5D % Chg

Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.

Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More

年頭旺到年尾

Aug 21, 2025 06:11

Are you foolish? What's the point of knowing your mistakes?

牛牛課堂

Sep 12, 2025 17:29

[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?